{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T13:06:44Z","timestamp":1749560804706,"version":"3.40.5"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,2]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>During the past 3 years of the corona virus disease 2019 (COVID-19) pandemic, COVID-19 has been recognized to cause various neurological complications, including rare posterior reversible encephalopathy syndrome (PRES). In previously reported cases of PRES associated with COVID-19, the majority of patients had severe COVID-19 infection and known predisposing factors for PRES, such as uncontrolled hypertension, renal dysfunction, and use of immunosuppressants. It remains unclear whether these risk factors or infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contributes to the development of PRES in these patients. Here we report a special case of PRES associated with COVID-19 without any known risk factors for PRES, indicating the SARS-CoV-2\u2019s direct role in the pathogenesis of PRES associated with COVID-19.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>An 18-year-old female patient presented to the emergency department with abdominal pain. Preliminary investigations showed no abnormalities, except for positive results in novel coronavirus nucleic acid tests using oropharyngeal swabs. However, the patient subsequently developed tonic\u2013clonic seizures, headaches, and vomiting on the second day. Extensive investigations have been performed, including brain MRI and lumbar puncture. Brain MRI showed hypointense T1-weighted and hyperintense T2-weighted lesions in the bilateral occipital, frontal, and parietal cortices without enhancement effect. Blood and cerebrospinal fluid analyses yielded negative results. The patient had no hypertension, renal insufficiency, autoimmune disease, or the use of immunosuppressants or cytotoxic drugs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>PRES was diagnosed based on the clinical features and typical MRI findings of PRES.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Symptomatic treatments such as anticonvulsants were administered to the patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient fully recovered within 1 week. The initial MRI abnormalities also disappeared completely on a second MR examination performed 11 days later, supporting the diagnosis of PRES. The patient was followed up for 6 months and remained in a normal state.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The current case had no classical risk factors for PRES, indicating that although the cause of PRES in COVID-19 patients may be multifactorial, the infection of SARS-CoV-2 may play a direct role in the pathogenesis of PRES associated with COVID-19.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037192","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T21:03:53Z","timestamp":1706907833000},"page":"e37192","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["SARS-CoV-2 may play a direct role in the pathogenesis of posterior reversible encephalopathy syndrome (PRES) associated with COVID-19: A CARE-compliant case report and literature review"],"prefix":"10.1097","volume":"103","author":[{"given":"Lishen","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weishuai","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0151-0964","authenticated-orcid":false,"given":"Dongming","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41392-021-00818-7","article-title":"Neurological complications and infection mechanism of SARS-CoV-2.","volume":"6","author":"Wan","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s00415-021-10406-y","article-title":"Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).","volume":"268","author":"Harapan","year":"2021","journal-title":"J Neurol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jocn.2021.03.028","article-title":"Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19.","volume":"88","author":"Lallana","year":"2021","journal-title":"J Clin Neurosci"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"103080","DOI":"10.1016\/j.amsu.2021.103080","article-title":"The association of posterior reversible encephalopathy syndrome with COVID-19: a systematic review.","volume":"72","author":"Iftikhar","year":"2021","journal-title":"Ann Med Surg (Lond)"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","article-title":"Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.","volume":"14","author":"Fugate","year":"2015","journal-title":"Lancet Neurol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"116943","DOI":"10.1016\/j.jns.2020.116943","article-title":"Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19.","volume":"414","author":"Kishfy","year":"2020","journal-title":"J Neurol Sci"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3174\/ajnr.A6793","article-title":"Brain imaging of patients with COVID-19: findings at an academic institution during the height of the outbreak in New York City.","volume":"41","author":"Lin","year":"2020","journal-title":"AJNR Am J Neuroradiol"},{"key":"R8-20250504","first-page":"421","article-title":"SARS-CoV-2 associated posterior reversible encephalopathy syndrome (PRES) - a review of 82 cases.","volume":"78","author":"Finsterer","year":"2023","journal-title":"Med J Malaysia"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.stem.2020.10.001","article-title":"SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids.","volume":"27","author":"Pellegrini","year":"2020","journal-title":"Cell Stem Cell"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7861\/clinmed.2019-0247","article-title":"Hypertensive brainstem encephalopathy: a diagnosis often overlooked.","volume":"19","author":"Tan","year":"2019","journal-title":"Clin Med (Lond)"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1111\/ene.14965","article-title":"Persistent visual dysfunction following posterior reversible encephalopathy syndrome due to COVID-19: case series and literature review.","volume":"28","author":"Hixon","year":"2021","journal-title":"Eur J Neurol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/00207454.2018.1561452","article-title":"Isolated brainstem involvement in posterior reversible encephalopathy syndrome: a case report and review of the literature.","volume":"129","author":"Liu","year":"2019","journal-title":"Int J Neurosci"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin.","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2.","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ Res"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41423-020-00616-1","article-title":"SARS-CoV-2 infection in K18-ACE2 transgenic mice replicates human pulmonary disease in COVID-19.","volume":"18","author":"Arce","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"977039","DOI":"10.3389\/fncel.2022.977039","article-title":"Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations.","volume":"16","author":"M\u00e9ndez-Garc\u00eda","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"687783","DOI":"10.3389\/fcvm.2021.687783","article-title":"SARS-CoV-2 spike protein induces degradation of junctional proteins that maintain endothelial barrier integrity.","volume":"8","author":"Raghavan","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/jcp.30047","article-title":"Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls.","volume":"236","author":"Sadeghi","year":"2021","journal-title":"J Cell Physiol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.7150\/thno.61810","article-title":"Endothelial cell infection and dysfunction, immune activation in severe COVID-19.","volume":"11","author":"Qin","year":"2021","journal-title":"Theranostics"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/v15030706","article-title":"COVID-19 and pulmonary angiogenesis: the possible role of hypoxia and hyperinflammation in the overexpression of proteins involved in alveolar vascular dysfunction.","volume":"15","author":"Miggiolaro","year":"2023","journal-title":"Viruses"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3390\/biomedicines9091220","article-title":"Endothelial cell activation by SARS-CoV-2 spike S1 protein: a crosstalk between endothelium and innate immune cells.","volume":"9","author":"Rotoli","year":"2021","journal-title":"Biomedicines"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"112107","DOI":"10.1016\/j.biopha.2021.112107","article-title":"Recent advances in management of COVID-19: a review.","volume":"143","author":"Mouffak","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"e7173","DOI":"10.1002\/ccr3.7173","article-title":"Posterior reversible encephalopathy syndrome in SARS-CoV-2 infection: a case report and review of literature.","volume":"11","author":"Ziaee","year":"2023","journal-title":"Clin Case Rep"},{"key":"R24-20250504","first-page":"e13475","article-title":"Posterior reversible encephalopathy syndrome in a patient with SARS-CoV-2 infection treated with tocilizumab.","volume":"13","author":"Talluri","year":"2021","journal-title":"Cureus"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4065\/mcp.2009.0590","article-title":"Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings.","volume":"85","author":"Fugate","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2017.06.044","article-title":"Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.","volume":"380","author":"Parikh","year":"2017","journal-title":"J Neurol Sci"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"295","DOI":"10.17712\/nsj.2021.3.20210002","article-title":"Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection.","volume":"26","author":"Al Haboob","year":"2021","journal-title":"Neurosciences (Riyadh)"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1016\/j.radcr.2022.06.081","article-title":"Posterior reversible encephalopathy syndrome on COVID-19.","volume":"17","author":"Suwanto","year":"2022","journal-title":"Radiol Case Rep"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/ATVBAHA.120.314860","article-title":"Endothelial dysfunction and thrombosis in patients with COVID-19-brief report.","volume":"40","author":"Nagashima","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/jth.15179","article-title":"Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia.","volume":"19","author":"Nicolai","year":"2021","journal-title":"J Thromb Haemost"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:21:37Z","timestamp":1746328897000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,2]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037192","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,2,2]]}}}